Canaccord Genuity analyst George Gianarikas reiterated a Buy rating on ASP Isotopes, Inc. (ASPI – Research Report) yesterday and set a price ...

Canaccord Genuity analyst Aravinda Galappatthige maintained a Hold rating on Telus (TU – Research Report) today and set a price target of ...

Fintel reports that on April 3, 2025, Canaccord Genuity initiated coverage of LifeStance Health Group (NasdaqGS:LFST) with a ...

Canaccord Genuity Group Inc. (TSX: CF) (the "Company") today announced a key step in the continued evolution of its strategy related to its U.S. capital markets business, Canaccord Genuity LLC. The ...

Fintel reports that on April 1, 2025, Canaccord Genuity initiated coverage of Arbe Robotics (NasdaqCM:ARBE) with a Buy ...

This week’s episode features Canaccord Genuity senior investment advisor Cam Currie in conversation with host Adrian ...

MARKER THERAPEUTICS, INC. (Nasdaq: MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell-based immunotherapies for the treatment of hematological malignancies ...

Sensei Biotherapeutics (Nasdaq: SNSE) is a clinical stage biotechnology company focused on the discovery and development of ...

Canaccord Genuity Group said Tuesday that it agreed to sell its U.S. wholesale market-making business as it looks to focus more on its investment-banking platform. The Toronto financial-services firm ...

Deal with Cantor Fitzgerald comes almost two years after Canaccord warned of a potentially ‘significant penalty’ related to ...

Analysts at Canaccord Genuity raised their target price on 'buy' rated software publisher Gaming Realms from 50.0p to 57.0p ...

LifeSpeak (TSE:LSPK – Get Free Report) had its price target dropped by equities researchers at Canaccord Genuity Group from ...